Clinical Trial Update: Genomic Predictors of Papillary Microcarcinoma Disease Progression

View source ↗

Summary

A Memorial Sloan Kettering study aims to identify genomic predictors of progression in papillary microcarcinoma and is currently recruiting participants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Papillary Thyroid Carcinoma
• Papillary Thyroid Microcarcinoma

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Papillary Microcarcinoma | Status: RECRUITING